Cargando…

Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine

Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Sarah M., Settles, Erik W., Davitt, Christopher, Gellings, Patrick, Kikendall, Nicole, Hoffmann, Joseph, Wang, Yihui, Bitoun, Jacob, Lodrigue, Kasi-Russell, Sahl, Jason W., Keim, Paul, Roy, Chad, McLachlan, James, Morici, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846723/
https://www.ncbi.nlm.nih.gov/pubmed/33514749
http://dx.doi.org/10.1038/s41541-021-00281-z
_version_ 1783644789460172800
author Baker, Sarah M.
Settles, Erik W.
Davitt, Christopher
Gellings, Patrick
Kikendall, Nicole
Hoffmann, Joseph
Wang, Yihui
Bitoun, Jacob
Lodrigue, Kasi-Russell
Sahl, Jason W.
Keim, Paul
Roy, Chad
McLachlan, James
Morici, Lisa A.
author_facet Baker, Sarah M.
Settles, Erik W.
Davitt, Christopher
Gellings, Patrick
Kikendall, Nicole
Hoffmann, Joseph
Wang, Yihui
Bitoun, Jacob
Lodrigue, Kasi-Russell
Sahl, Jason W.
Keim, Paul
Roy, Chad
McLachlan, James
Morici, Lisa A.
author_sort Baker, Sarah M.
collection PubMed
description Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4(+), and CD8(+) T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis.
format Online
Article
Text
id pubmed-7846723
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78467232021-02-08 Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine Baker, Sarah M. Settles, Erik W. Davitt, Christopher Gellings, Patrick Kikendall, Nicole Hoffmann, Joseph Wang, Yihui Bitoun, Jacob Lodrigue, Kasi-Russell Sahl, Jason W. Keim, Paul Roy, Chad McLachlan, James Morici, Lisa A. NPJ Vaccines Article Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4(+), and CD8(+) T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis. Nature Publishing Group UK 2021-01-29 /pmc/articles/PMC7846723/ /pubmed/33514749 http://dx.doi.org/10.1038/s41541-021-00281-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Baker, Sarah M.
Settles, Erik W.
Davitt, Christopher
Gellings, Patrick
Kikendall, Nicole
Hoffmann, Joseph
Wang, Yihui
Bitoun, Jacob
Lodrigue, Kasi-Russell
Sahl, Jason W.
Keim, Paul
Roy, Chad
McLachlan, James
Morici, Lisa A.
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_full Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_fullStr Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_full_unstemmed Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_short Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_sort burkholderia pseudomallei omvs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846723/
https://www.ncbi.nlm.nih.gov/pubmed/33514749
http://dx.doi.org/10.1038/s41541-021-00281-z
work_keys_str_mv AT bakersarahm burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT settleserikw burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT davittchristopher burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT gellingspatrick burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT kikendallnicole burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT hoffmannjoseph burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT wangyihui burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT bitounjacob burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT lodriguekasirussell burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT sahljasonw burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT keimpaul burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT roychad burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT mclachlanjames burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT moricilisaa burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine